Abstract
The intracameral use of antibiotics following cataract surgery significantly reduces the risk of postoperative endophthalmitis when compared to the pre- or postoperative use of topical antibiotics. The prophylactic use of this therapeutic regimen is a current practice in Europe and in a large number of countries around the world. It is not routinely followed in the US because no commercial antibiotic for intracameral use has been approved by the Food and Drug Administration. With this update on the topic, the Brazilian Society for Cataract and Refractive Surgery intends to show the positive impact of the intracameral use of antibiotics on reducing the rates of endophthalmitis following cataract surgery and highlights evidence of good outcomes that reinforce the safety and efficacy of this prophylactic therapeutic regimen.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
